MA37532B1 - Pharmacological composition of palmarosa (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans - Google Patents

Pharmacological composition of palmarosa (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans

Info

Publication number
MA37532B1
MA37532B1 MA37532A MA37532A MA37532B1 MA 37532 B1 MA37532 B1 MA 37532B1 MA 37532 A MA37532 A MA 37532A MA 37532 A MA37532 A MA 37532A MA 37532 B1 MA37532 B1 MA 37532B1
Authority
MA
Morocco
Prior art keywords
palmarosa
essential oil
antibacterial effect
actinomycetemcomitans
aaggregatibacter
Prior art date
Application number
MA37532A
Other languages
French (fr)
Other versions
MA37532A1 (en
Inventor
Leila Lakhdar
Abdellah Farah
Oumkeltoum Ennibi
Original Assignee
Université Mohammed V De Rabat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université Mohammed V De Rabat filed Critical Université Mohammed V De Rabat
Priority to MA37532A priority Critical patent/MA37532B1/en
Priority to PCT/MA2014/000057 priority patent/WO2016076688A1/en
Publication of MA37532A1 publication Critical patent/MA37532A1/en
Publication of MA37532B1 publication Critical patent/MA37532B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

L’application de l’effet antibactérien de l’huile essentielle de palmarosa (cymbopogon martinii) d’origine marocaine sur une souche bactérienne orale virulente; aggregatibacter actinomycetemcomitans clone jp2. Cette souche originelle n’a jamais fait l’objet de tests antimicrobiens à base d'huiles essentielles. Cette nouvelle application englobe aussi bien la méthodologie que les résultats obtenus. La technique utilisée est une méthode simple, claire, basée sur la preuve et offrant une meilleure précision et une meilleure reproductibilité des résultats.The application of the antibacterial effect of the essential oil of palmarosa (cymbopogon martinii) of Moroccan origin on a virulent oral bacterial strain; aggregatibacter actinomycetemcomitans clone jp2. This original strain has never been the subject of antimicrobial tests based on essential oils. This new application encompasses both the methodology and the results obtained. The technique used is a simple, clear, evidence-based method with improved accuracy and reproducibility of results.

MA37532A 2014-11-13 2014-11-13 Pharmacological composition of palmarosa (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans MA37532B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MA37532A MA37532B1 (en) 2014-11-13 2014-11-13 Pharmacological composition of palmarosa (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
PCT/MA2014/000057 WO2016076688A1 (en) 2014-11-13 2014-12-31 Pharmacological composition of palmarosa (essential oil) exhibiting an antibacterial effect on the jp2 clone of aggregatibacter actinomycetemcomitans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA37532A MA37532B1 (en) 2014-11-13 2014-11-13 Pharmacological composition of palmarosa (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans

Publications (2)

Publication Number Publication Date
MA37532A1 MA37532A1 (en) 2016-06-30
MA37532B1 true MA37532B1 (en) 2017-01-31

Family

ID=52684612

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37532A MA37532B1 (en) 2014-11-13 2014-11-13 Pharmacological composition of palmarosa (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans

Country Status (2)

Country Link
MA (1) MA37532B1 (en)
WO (1) WO2016076688A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007210922A (en) * 2006-02-08 2007-08-23 Kitasato Gakuen Oral composition

Also Published As

Publication number Publication date
MA37532A1 (en) 2016-06-30
WO2016076688A1 (en) 2016-05-19

Similar Documents

Publication Publication Date Title
CL2020001048A1 (en) Monoclonal antibodies against bcma. (divisional request 201800281)
CL2021000343A1 (en) Interleukin 23 Receptor Peptide Inhibitors (Divisional Application No. 201800128)
CY1122306T1 (en) COMPOSITIONS CONTAINING BAKTHPIAKA STRAIN
MA49903A (en) SULPHONYLURIDES AND SULPHONYLTHIOURIDES AS NLRP3 INHIBITORS
AR106768A1 (en) COMPOSITIONS THAT INCLUDE BACTERIAL VINTAGES
NZ725569A (en) Lubricant formulations
MA46109A (en) HIGH CONCENTRATE, LOW VISCOSITY MASP-2 INHIBITOR ANTIBODY FORMULATIONS, KITS AND METHODS
MA48797A (en) CBLB ENDONUCLEASE VARIANTS, COMPOSITIONS AND METHODS OF USE
BR112017005762A2 (en) Enhancements in Muscle Functionality of Male Seniors
CY1124338T1 (en) 3-PHOSPHOGLYCERATE DEHYDROGENATION INHIBITORS AND THEIR USES
ITUA20161822A1 (en) USEFUL COMPOSITIONS IN THE PREVENTION AND / OR IN THE TREATMENT OF ORAL CABLE PATHOLOGIES, OF THE FIRST AIRWAYS AND OF THE ESOFAGO
BR102019017062A8 (en) TOPICAL COMPOSITIONS INCLUDING PICHIA ANOMALA AND RETINOL
MX2021006977A (en) Anellosomes and methods of use.
FR3039749B1 (en) HYPERENERGETIC NUTRITIONAL COMPOSITION AND PROTEIN ENRICHED
MA37532B1 (en) Pharmacological composition of palmarosa (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
MA37534B1 (en) Pharmacological composition of thyme (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
MA37530A1 (en) Pharmacological composition of citronella (essential oil) with antibacterial effect on aggregatibacter actinomycetemcomitans
MA37533B1 (en) Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
BR102019017344A8 (en) TOPICAL COMPOSITIONS COMPRISING PICHIA ANOMALA AND N-ACETYL GLYCOSAMINE
MA37531A1 (en) Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
MA37529A1 (en) Pharmacological composition of pennyroyal mint (essential oil) with antibacterial effect on the aggregatibacter actinomycetemcomitans.
CL2018002949A1 (en) Compositions for oral care.
AU2015205151A1 (en) 5-hydroxy-1H-imidazole-4-carboxamide effective-dose/sensitivity prediction method and prediction device, xanthosine-monophosphate-amount measurement method, and myelodysplastic-syndrome treatment agent and treatment method
MA49960A (en) HIGH CONCENTRATED, LOW VISCOSITY MASP-2 INHIBITOR ANTIBODY FORMULATIONS, KITS AND METHODS OF TREATMENT OF SUBJECTS WITH ATYPICAL HEMOLYTIC SYNDROME
CL2017002192A1 (en) Method for estimating individual olive oil based on non-destructive technologies.